Two Connecticut communities recently filed separate but identical federal lawsuits accusing major insulin manufacturers and pharmacy benefit managers of orchestrating a long-running scheme that artificially inflated the cost of diabetes medications.
CVS Health Corp. released its second-quarter earnings report on Thursday, beating Wall Street analyst expectations and once again raising its full-year forecast.